Trial intelligence / Profile preview

Comparison of short-term consequences of calcium bolus administration with continuous infusion in intravenous feeding of preterm infants

IRCT20210913052466N1Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Sep 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of calcium (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Short-term clinical consequences of calcium administration mode. Started Sep 2021; status: completed.

02

Drugs

calcium

Beyond the preview

Go deeper on IRCT20210913052466N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210913052466N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call